← Open Payments lookup

LAUREN HARR: Open Payments

NPI 1013393669 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,818 in 118 payments from 20 companies in 2025. Trend: 2023 $3,223 · 2024 $3,001 · 2025 $2,818

Food & beverage: $2,818
CompanyPaymentsAmount
GENZYME CORPORATION10$391
Regeneron Healthcare Solutions, Inc.15$391
UCB, Inc.16$384
Novartis Pharmaceuticals Corporation10$302
Arcutis Biotherapeutics, Inc.17$260
MERZ NORTH AMERICA, INC.2$170
Galderma Laboratories, L.P.11$167
SUN PHARMACEUTICAL INDUSTRIES INC.5$137
Almirall LLC6$120
ABBVIE INC.5$96

Products named: DUPIXENT, Bimzelx, Zoryve, Rhapsido, Xeomin, NEMLUVIO, LIBTAYO, Klisyri.

Industry payments across TX — which companies pay providers there.